Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3CNS 3Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 4Fatigue 3

Interventions

Therapeutics 5Methylphenidate 3Exercise 3Sunitinib 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2isoquercitrin 1enzalutamide 1darolutamide 1apalutamide 1Transcranial Magnetic Stimulation 1Surveys and Questionnaires 1Sugars 1Qigong 1Nutritional Support 1Neurofeedback 1Methods 1Lactose 1High-Intensity Interval Training 1Epoetin Alfa 1Early Intervention, Educational 1Dexamethasone 1Darbepoetin alfa 1Creatine 1Counseling 1Cognitive Behavioral Therapy 1Acupuncture Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Fatigue × Methylphenidate × Genitourinary × Clear all
NCT01410942 2026-02-20

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
175 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT00593853 2014-06-04

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

University Health Network, Toronto

Phase 2 Terminated
33 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT00138138 2007-12-10

Psychostimulants for Fatigue in Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
120 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡